Harbor Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Hold
1,300
0.2% 59
2026
Q1
$1.2M Buy
1,300
+400
+44% +$406K 0.17% 67
2025
Q4
$967K Hold
900
0.15% 78
2025
Q3
$687K Hold
900
0.11% 99
2025
Q2
$702K Hold
900
0.11% 97
2025
Q1
$743K Hold
900
0.13% 88
2024
Q4
$695K Hold
900
0.11% 95
2024
Q3
$797K Hold
900
0.13% 84
2024
Q2
$815K Hold
900
0.15% 78
2024
Q1
$700K Buy
900
+400
+80% +$285K 0.13% 88
2023
Q4
$291K Hold
500
0.06% 136
2023
Q3
$269K Hold
500
0.06% 129
2023
Q2
$234K Buy
+500
New +$210K 0.05% 122

Other funds holding LLY

Harbor Advisors's LLY Position: Q2 2026 in Review

Harbor Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,300 shares worth $1.56M. The position accounts for 0.2% of the portfolio, ranked #59.

Harbor Advisors first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 1,855 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harbor Advisors held 1,300 shares of Eli Lilly worth $1.56M as of Q2 2026.
  • Harbor Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.2% of Harbor Advisors's portfolio in Q2 2026, its #59 holding.
  • Harbor Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 1,855 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harbor Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.